| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Revenue | $32.0B | $26.1B | $32.6B | $11.0B |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| R&D Expense | — | — | — | — |
| SG&A Expense | — | — | — | — |
| Operating Income | — | — | — | — |
| Net Income | $3.5B | $4.6B | $5.0B | $-3.2B |
| EPS (Basic) | $5.58 | $7.39 | $8.32 | $-5.57 |
| EPS (Diluted) | $5.54 | $7.33 | $8.28 | $-5.57 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Total Assets | $460.9B | $377.9B | $313.5B | $259.3B |
| Current Assets | — | — | — | — |
| Cash & Equivalents | — | — | — | $9.0B |
| Total Liabilities | $418.4B | $346.9B | $288.2B | $252.1B |
| Current Liabilities | — | — | — | — |
| Stockholders' Equity | $23.3B | $17.3B | $14.0B | $0.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Operating Cash Flow | $7.2B | $3.3B | $6.3B | $3.8B |
| Investing Cash Flow | $-64.0B | $-61.8B | $-42.4B | $-23.4B |
| Capital Expenditures | — | — | — | — |
| Financing Cash Flow | $60.2B | $58.0B | $42.6B | $28.7B |